144 related articles for article (PubMed ID: 23776774)
1. Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective.
Nandha R; Gupta A; Hashmi A
Int J Appl Basic Med Res; 2011 Jan; 1(1):50-3. PubMed ID: 23776774
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous adverse drug reactions in Indian population: A systematic review.
Patel TK; Thakkar SH; Sharma D
Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
[TBL] [Abstract][Full Text] [Related]
4. A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.
Sinha S; Kar C; Das S; Dutta A; De A
Indian J Dermatol; 2024; 69(1):106. PubMed ID: 38572036
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
[TBL] [Abstract][Full Text] [Related]
6. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
[TBL] [Abstract][Full Text] [Related]
7. Morphological Pattern of Cutaneous Adverse Drug Reactions due to Antiepileptic Drugs in Eastern India.
Singh PK; Kumar MK; Kumar D; Kumar P
J Clin Diagn Res; 2015 Jan; 9(1):WC01-3. PubMed ID: 25738068
[TBL] [Abstract][Full Text] [Related]
8. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
Mittal N; Gupta M; Singla M
Cutan Ocul Toxicol; 2014 Dec; 33(4):289-93. PubMed ID: 24517496
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Analysis of Pattern of Cutaneous Adverse Drug Reactions in Tertiary Hospital of Pauri Garhwal.
Dimri D; Raina RS; Thapliyal S; Thawani V
J Clin Diagn Res; 2016 May; 10(5):FC01-6. PubMed ID: 27437240
[TBL] [Abstract][Full Text] [Related]
11. A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India.
Sharma R; Dogra D; Dogra N
Indian Dermatol Online J; 2015; 6(3):168-71. PubMed ID: 26009710
[TBL] [Abstract][Full Text] [Related]
12. Pharmacovigilance of Cutaneous Adverse Drug Reactions among Patients Attending Dermatology Department at a Tertiary Care Hospital.
Sharma S; Jayakumar D; Palappallil DS
Indian Dermatol Online J; 2019; 10(5):547-554. PubMed ID: 31544074
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Clinical Spectrum of Cutaneous Adverse Drug Reactions in Patients Presenting at a Tertiary Care Hospital in Pakistan.
Hina A; Masood S; Jamil S; Tabassum S; Jalil P; Ghulam U
Cureus; 2021 Apr; 13(4):e14568. PubMed ID: 34026384
[TBL] [Abstract][Full Text] [Related]
14. Clinical Pattern and Causality Assessment of Drug-induced Cutaneous Reactions in a Tertiary Care Hospital in India: A Prospective Study.
James J; Mohamed AB; Hussain FS; Rani J; Varadarajan S
Curr Drug Saf; 2022; 17(3):193-198. PubMed ID: 34702154
[TBL] [Abstract][Full Text] [Related]
15. An observational study of cutaneous adverse drug reactions in a teaching hospital.
Chopra D; Sharma V; Kapoor R; Dwivedi S
Int J Clin Pharm; 2015 Dec; 37(6):996-9. PubMed ID: 26238222
[TBL] [Abstract][Full Text] [Related]
16. Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions.
Beniwal R; Gupta LK; Khare AK; Mittal A; Mehta S; Balai M
Indian Dermatol Online J; 2019; 10(1):27-33. PubMed ID: 30775295
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous adverse drug reactions among people living with human immunodeficiency virus in a tertiary care hospital in Johor, Malaysia.
Chua KY; Tey KE
Int J STD AIDS; 2022 Aug; 33(9):812-820. PubMed ID: 35775121
[TBL] [Abstract][Full Text] [Related]
18. Association of
John S; Balakrishnan K; Sukasem C; Anand TCV; Canyuk B; Pattharachayakul S
J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442381
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Adverse Drug Reactions (CADRs)-Statistical Analysis of the Causal Relationship between the Drug, Comorbidities, Cofactors, and the Cutaneous Reaction-A Single-Centered Study.
MachoĊ N; Lewandowska J; Zdanowska N; Placek W; Owczarczyk-Saczonek A
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805639
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital.
Sushma M; Noel MV; Ritika MC; James J; Guido S
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):567-70. PubMed ID: 15937869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]